Perrigo Company PLC
PRGO21.190USD
-0.060-0.28%
收盤 10/13, 16:00（美東）報價延遲15分鐘
2.92B總市值
虧損本益比TTM
關於 Perrigo Company PLC 公司
Perrigo Company plc 是一家非處方 (OTC) 健康和保健解決方案提供商，旨在提高個人健康水平。其部門包括消費者自我護理美洲 (CSCA) 和消費者自我護理國際 (CSCI)。CSCA 部門包括其在美國和加拿大的消費者自我護理業務。它主要爲客戶提供以客戶自有品牌和/或獨家品牌銷售和營銷的自我護理產品。CSCI 部門包括其在美國和加拿大以外的消費者自我護理業務，主要是在歐洲和澳大利亞。這些產品由公司開發、製造、營銷和分銷。其產品類別包括上呼吸道、疼痛和助眠劑、護膚和個人衛生、消化健康和營養。其主要品牌產品以 Compeed、Dr. Fresh、Firefly、Good Sense、Mederma、Nasonex、Solpadeine、Coldrex 和 Physiomer 等品牌銷售。
Perrigo Company PLC簡介
公司代碼PRGO
公司名稱Perrigo Company PLC
上市日期Dec 17, 1991
CEOMr. Patrick Lockwood-Taylor
員工數量8379
證券類型Ordinary Share
年結日Dec 17
公司地址The Sharp Building
城市DUBLIN
上市交易所NYSE Consolidated
國家Ireland
郵編D02 TY74
電話3532696738451
網址https://www.perrigo.com/
公司代碼PRGO
上市日期Dec 17, 1991
CEOMr. Patrick Lockwood-Taylor
Perrigo Company PLC公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
Ms. Adriana (Andi) Karaboutis
Ms. Adriana (Andi) Karaboutis
Independent Director
Independent Director
27.63K
+22.91%
Mr. Orlando D. Ashford
Mr. Orlando D. Ashford
Independent Chairman of the Board
Independent Chairman of the Board
22.17K
+40.91%
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Mr. Jeffrey B. (Jeff) Kindler, Esq.
Independent Director
Independent Director
10.56K
+95.21%
Ms. Julia M. Brown
Ms. Julia M. Brown
Independent Director
Independent Director
8.03K
+178.57%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Patrick Lockwood-Taylor
Mr. Patrick Lockwood-Taylor
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.81K
+5.48%
Mr. Geoffrey M. (Geoff) Parker
Mr. Geoffrey M. (Geoff) Parker
Independent Director
Independent Director
60.29K
+16.75%
Mr. Eduardo Guarita Bezerra
Mr. Eduardo Guarita Bezerra
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
48.95K
+6.53%
Mr. Robert Willis
Mr. Robert Willis
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
41.94K
+3.68%
Mr. Bradley A. (Brad) Alford
Mr. Bradley A. (Brad) Alford
Independent Director
Independent Director
41.16K
+14.30%
Mr. Donal O'Connor
Mr. Donal O'Connor
Independent Director
Independent Director
31.84K
+19.30%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
其他
299.20M
28.33%
地區USD
名稱
營收
佔比
United States
610.90M
57.83%
Europe
421.70M
39.92%
All other countries
23.70M
2.24%
業務
地區
業務USD
名稱
營收
佔比
Skincare and personal hygiene
180.70M
17.11%
Upper respiratory
178.70M
16.92%
Pain and sleep-aids
143.70M
13.60%
Healthy lifestyle
134.40M
12.72%
Digestive health
119.60M
11.32%
其他
299.20M
28.33%
股東統計
更新時間: 8月16日 週六
更新時間: 8月16日 週六
持股股東
股東類型
持股股東
持股股東
佔比
T. Rowe Price Associates, Inc.
10.49%
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.55%
Dimensional Fund Advisors, L.P.
5.46%
State Street Global Advisors (US)
5.34%
其他
60.02%
持股股東
持股股東
佔比
T. Rowe Price Associates, Inc.
10.49%
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.55%
Dimensional Fund Advisors, L.P.
5.46%
State Street Global Advisors (US)
5.34%
其他
60.02%
股東類型
持股股東
佔比
Investment Advisor
61.46%
Investment Advisor/Hedge Fund
33.51%
Hedge Fund
5.68%
Research Firm
1.96%
Pension Fund
1.49%
Sovereign Wealth Fund
1.05%
Bank and Trust
0.64%
Individual Investor
0.45%
Family Office
0.05%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
759
145.63M
105.85%
-23.73M
2025Q2
791
145.85M
106.01%
-21.49M
2025Q1
812
142.34M
103.61%
-25.15M
2024Q4
806
140.28M
102.80%
-22.73M
2024Q3
798
138.34M
101.41%
-20.68M
2024Q2
800
136.29M
99.93%
-16.34M
2024Q1
799
135.97M
99.77%
-20.56M
2023Q4
809
135.31M
99.86%
-23.17M
2023Q3
797
133.80M
98.82%
-17.47M
2023Q2
837
137.28M
101.45%
-14.92M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
T. Rowe Price Associates, Inc.
14.43M
10.49%
+143.89K
+1.01%
Jun 30, 2025
The Vanguard Group, Inc.
13.96M
10.15%
+58.03K
+0.42%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
11.76M
8.55%
-46.83K
-0.40%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
7.51M
5.46%
+377.67K
+5.29%
Jun 30, 2025
State Street Global Advisors (US)
7.34M
5.34%
+637.68K
+9.51%
Jun 30, 2025
DePrince, Race & Zollo, Inc.
4.56M
3.32%
-7.61K
-0.17%
Jun 30, 2025
Ion Asset Management Israel Ltd
3.82M
2.77%
+983.73K
+34.71%
Jun 30, 2025
Neuberger Berman, LLC
3.71M
2.7%
-88.92K
-2.34%
Jun 30, 2025
Cooke & Bieler, L.P.
3.30M
2.4%
-241.34K
-6.82%
Jun 30, 2025
Sound Shore Management, Inc.
3.29M
2.39%
+2.50K
+0.08%
Jun 30, 2025
查看更多
持股ETF
更新時間: 10月6日 週一
更新時間: 10月6日 週一
機構名稱
佔比
Sound Equity Dividend Income ETF
3.77%
SPDR S&P Pharmaceuticals ETF
2.85%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
2.76%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.08%
Invesco Pharmaceuticals ETF
2.06%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
1.59%
iShares U.S. Pharmaceuticals ETF
1.52%
Invesco High Yield Equity Dividend Achievers ETF
1.4%
Cultivar ETF
1.3%
Invesco S&P MidCap 400 Pure Value ETF
1.3%
查看更多
Sound Equity Dividend Income ETF
佔比3.77%
SPDR S&P Pharmaceuticals ETF
佔比2.85%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
佔比2.76%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比2.08%
Invesco Pharmaceuticals ETF
佔比2.06%
ProShares S&P MidCap 400 Dividend Aristocrats ETF
佔比1.59%
iShares U.S. Pharmaceuticals ETF
佔比1.52%
Invesco High Yield Equity Dividend Achievers ETF
佔比1.4%
Cultivar ETF
佔比1.3%
Invesco S&P MidCap 400 Pure Value ETF
佔比1.3%
分紅派息
近5年累計派現
698.10M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 19, 2025
PRGO.NB Interim Cash Dividend of gross USD 0.29 paid on Mar 25, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 25, 2025
Mar 07, 2025
Nov 01, 2024
PRGO.NB Final Cash Dividend of gross USD 0.276 paid on Dec 17, 2024 going ex on Nov 29, 2024
Nov 29, 2024
Dec 17, 2024
Nov 29, 2024
Aug 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Sep 17, 2024 going ex on Aug 30, 2024
Aug 30, 2024
Sep 17, 2024
Aug 30, 2024
May 01, 2024
PRGO.NB Interim Cash Dividend of gross USD 0.276 paid on Jun 18, 2024 going ex on May 31, 2024
May 31, 2024
Jun 18, 2024
May 31, 2024
Feb 26, 2024
PRGO.NB Interim Cash Dividend of gross USD 1.1 paid on Mar 26, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 26, 2024
Mar 07, 2024
Nov 03, 2023
PRGO.NB Final Cash Dividend of gross USD 0.273 paid on Dec 19, 2023 going ex on Nov 30, 2023
Dec 01, 2023
Dec 19, 2023
Nov 30, 2023
Aug 02, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Sep 19, 2023 going ex on Aug 31, 2023
Sep 01, 2023
Sep 19, 2023
Aug 31, 2023
May 04, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Jun 20, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jun 20, 2023
Jun 01, 2023
Feb 21, 2023
PRGO.NB Interim Cash Dividend of gross USD 0.273 paid on Mar 28, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 28, 2023
Mar 09, 2023
Nov 04, 2022
PRGO.NB Final Cash Dividend of gross USD 0.26 paid on Dec 20, 2022 going ex on Dec 01, 2022
Dec 02, 2022
Dec 20, 2022
Dec 01, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
